Christopher Carlson Email & Phone Number | I have more than twenty-five years of experience in phase I, II and III clinical trials in the pharmaceutical/biotechnology industry. As a Clinical Research Scientist, I have developed protocols, statistical analysis plans, authored manuscripts, clinical study reports and regulatory documents submitted to regulatory agencies including leading the annual updates to the Investigator Brochures and Developmental Safety Update for Regulatory. As a CRS for global Alzheimer's disease studies at Eli Lilly, I provided medical input and support for patient management and safety monitoring via leading Trial Level Safety Review, collaborating with Global Patient Safety in compound level review and MedDRA adverse event coding review. I also authored manuscripts and presented material at international congresses and advisory boards.

Christopher Carlson

I have more than twenty-five years of experience in phase I, II and III clinical trials in the phar...
Indianapolis, Indiana, United States

*50 free lookup(s) per month.

Christopher Carlson’s Email ccarlson@alzdiscovery.org

Christopher Carlson’s Phone Numbers

Social Media

Christopher Carlson’s Location Indianapolis, Indiana, United States

Christopher Carlson’s Current Industry

Christopher Carlson’s Prior Industry Alzheimers Drug Discovery Foundation | Cook Myosite | Eli Lilly

Find accurate emails & phone numbers for over 700M professionals.

Director of Search and Evaluation

2023-01-01 00:00:00 - 2024-06-01 00:00:00

Senior Clinical Research Scientist

2018-01-01 00:00:00 - 2022-12-01 00:00:00

Sr. Clinical Research Scientist

2008-05-01 00:00:00 - 2017-12-01 00:00:00

No Skills Available

No Languages Available

Christopher Carlson is a I have more than twenty-five years of experience in phase I, II and III clinical trials in the pharmaceutical/biotechnology industry. As a Clinical Research Scientist, I have developed protocols, statistical analysis plans, authored manuscripts, clinical study reports and regulatory documents submitted to regulatory agencies including leading the annual updates to the Investigator Brochures and Developmental Safety Update for Regulatory. As a CRS for global Alzheimer's disease studies at Eli Lilly, I provided medical input and support for patient management and safety monitoring via leading Trial Level Safety Review, collaborating with Global Patient Safety in compound level review and MedDRA adverse event coding review. I also authored manuscripts and presented material at international congresses and advisory boards.